DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 5 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,303,254 | +11.8% | 291,351 | -2.2% | 0.50% | +17.2% |
Q2 2023 | $3,849,708 | +27.8% | 297,965 | -3.0% | 0.43% | +16.8% |
Q1 2023 | $3,012,416 | -7.8% | 307,076 | 0.0% | 0.37% | -11.1% |
Q4 2022 | $3,267,289 | +21.3% | 307,076 | +19.0% | 0.41% | -10.6% |
Q3 2022 | $2,694,000 | +1008.6% | 258,009 | +1238.8% | 0.46% | +684.7% |
Q2 2022 | $243,000 | +16.3% | 19,271 | 0.0% | 0.06% | +40.5% |
Q1 2022 | $209,000 | -61.4% | 19,271 | -50.0% | 0.04% | -23.6% |
Q4 2021 | $542,000 | +46.5% | 38,542 | +100.0% | 0.06% | -32.1% |
Q3 2021 | $370,000 | – | 19,271 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |